General Meeting held in closed session at 5pm CET on December 15, 2020
Shareholders are asked to give their assent to the appointment of Elisabeth Kogan to the Supervisory Board of MedinCell
Elisabeth Kogan is currently CEO of Clexio Biosciences, she co-founded in 2018
She has held senior executive leadership roles at Teva Phamarceuticals between 2002 and 2018:
• Senior Vice-President of InnoTech, a Specialty R&D unit, in charge of developing new therapeutic entities and innovative technologies
• SVP Global Generic R&D, responsible for developing the company’s global generic pipeline
• VP Global Sales & Marketing, API Division
An introduction video conference will be held on December 1st, 2020 at 6:30pm
Contacts
Convening of the General Assembly: Proposal for the appointment of Elisabeth Kogan to the Supervisory Board
November 9, 2020